Drug giant Bayer acquires RTP gene therapy startup AskBio for as much as $4B
Drug giant Bayer is paying quite a price to acquire RTP gene therapy startup AskBio in a deal announced early today – as much as $4 billion.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
